Med Tech Solutions (MTS) puts the unique needs of each healthcare organization at the center of our work across the full IT journey. Our healthcare-exclusive services employ dedicated ITCare Teams to ensure technology systems support essential clinical workflows and strategic business plans. Provider organizations and networks can count on a secure, reliable IT infrastructure, optimized clinical and business applications, revenue cycle management services, and full end-user support so they can focus on patient care.
MTS was founded in 2006 in Valencia, California, and serves thousands of healthcare organizations nationwide. The company is the top-ranked IT services firm for healthcare organizations on the elite Channel Futures MSP 501 list and has been recognized as a 2023 CRN Pioneer 250 Honoree. MTS has achieved HITRUST Risk-based certification for its cloud platform, demonstrating a proactive approach to cybersecurity, data protection, and risk management.
Learn more at www.medtechsolutions.com.
Orgenesis is a vertically integrated global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format. The Orgenesis Point of Care Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The Network brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies. Learn more about the work Orgenesis is doing at www.orgenesis.com.
Orgenesis Belgium is an affiliate company of Orgenesis Inc. This location carries out process development and validation to support the global commercialization of proprietary and licensed advanced therapies using automated, closed-system technologies.